目的：了解中医药治疗高血压领域的研究现状及研究热点,为该领域研究者提供相关信息。方法：以Web of Science核心数据库和中国知识资源总库(CNKI)为数据源,运用CiteSpace5.7.R2科学知识图谱工具绘制、分析相关数据。结果：Web of Science核心数据库纳入841篇文献,中国知识资源总库(CNKI)纳入3182篇文献,经分析得到国际与国内的发文量最多的作者分别是：XINGJIANG XIONG和吕圭源；发表论文的作者较为分散,国际13位核心作者累计发文150篇,仅占全部文献的17.84%,国内120位核心作者累计发文671篇,占全部文献的21.67%；该领域研究机构的主力军为中医药高等院校及附属医院；关键词聚类呈现三个研究热点：①中医药治疗高血压临床疗效观察②中医药治疗高血压的生物学机制③数据挖掘中医药治疗高血压临床用药规律。结论：中医药治疗高血压领域的发文量整体呈上升趋势,中国在该领域占国际主导地位,但各机构、团队之间合作不够密切,随着研究范围的扩充和研究层次的深入,研究机构应加强机构间的合作,打破研究壁垒,形成新型知识共享、难点共破的学术氛围。
: Objective To understand the research status and hot spots in the field of Traditional Chinese Medicine (TCM) treatment of hypertension.Methods The literature about treatment of hypertension with TCM were retrieved from Web of Science and China Knowledge Resource Database (CNKI), and the scientific knowledge map tool CiteSpace5.7.R2 was used to draw and analyze relevant data. Results 841 and 3182 studies were included from Web of Science,CNKI respectively. The top 13 authors from English literature published 150 papers, accounting for only 17.84% of the total literatures, while the domestic top 120 authors published 671 papers, accounting for 21.67% of the total literatures. The main research institutions in this field are TCM universities and their affiliated hospitals. Keywords Clustering presents three research hotspots: ① observation of clinical efficacy of treatment of hypertension with TCM ② biological mechanism of treatment of hypertension with TCM ③ data mining of clinical medication rules of treatment of hypertension with TCM. Conclusion The annual number of published studies of treatment of hypertension TCM is on the rise, China was in the leading position internationally, but not enough closely cooperated between institutions, team, along with the expansion of research scope and the deepening of the research level.